The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Alginate lyase enhances antibiotic killing of mucoid Pseudomonas aeruginosa in biofilms
Abstract
Once mucoid (alginate‐producing) strains of Pseudomonas aeruginosa have become established in the respiratory tracts of cystic fibrosis patients they can rarely be eliminated by antibiotic treatment alone; we have investigated, in an in vitro biofilm system, the putative role of co‐administration of alginate lyase with antibiotic. Biofilms were maintained in continuous flow culture in a medium resembling sputum from CF patients. Antibiotics and/or alginate lyase were added to some of the cultures. Biofilms of two mucoid CF strains of P. aeruginosa were, in most cases, not eradicated by a one‐week course of treatment with 64 μg/ml of gentamicin; the same concentration of gentamicin, under the same conditions, led to the apparent elimination of all biofilms of non‐mucoid derivatives of these strains. When alginate lyase and gentamicin were administered together the apparent elimination of mucoid bacteria from biofilms was achieved, whereas the mucoid bacteria in most control biofilms treated only with gentamicin persisted. Ceftazidime treatment of biofilms was more effective against those containing the non‐mucoid strains than those with mucoid strains. These studies support the view that co‐administration of antibiotics with alginate lyase, which degrades the exopolysaccharide produced by mucoid strains of P aeruginosa, might benefit CF patients by increasing the efficacy of antibiotic in the respiratory tract.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bacterial Biofilms: A Common Cause of Persistent Infections
Costerton, J. W., Stewart, P. S., & Greenberg, E. P. (1999) · Science · doi:10.1126/science.284.5418.1318 · Cited by 12,167 · cited 1×
“the respiratory tract in a form similar to biofilms, layers of bacteria attached to surfaces that are found in many persistent infections (3).”
BackgroundMicrobial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia
Govan, J. R. W., & Deretic, V. P. (1996) · Microbiological Reviews · doi:10.1128/mmbr.60.3.539-574.1996 · Cited by 1,812
Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms
Singh, P. K., Schaefer, A. L., Parsek, M. R., Moninger, T. O., Welsh, M. J., & Greenberg, E. P. (2000) · Nature · doi:10.1038/35037627 · Cited by 1,519
A genetic basis for Pseudomonas aeruginosa biofilm antibiotic resistance
Mah, T.-F., Pitts, B., Pellock, B., Walker, G. C., Stewart, P. S., & O'Toole, G. A. (2003) · Nature · doi:10.1038/nature02122 · Cited by 1,190
The Formation of 2-Keto-3-deoxyheptonic Acid in Extracts of Escherichia coli B
Weissbach, A., & Hurwitz, J. (1959) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)70158-0 · Cited by 832
Alginate Overproduction Affects Pseudomonas aeruginosa Biofilm Structure and Function
Hentzer, M., Teitzel, G. M., Balzer, G. J., Heydorn, A., Molin, S., Givskov, M., & Parsek, M. R. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.18.5395-5401.2001 · Cited by 693
Wong, T. Y., Preston, L. A., & Schiller, N. L. (2000) · Annual Review of Microbiology · doi:10.1146/annurev.micro.54.1.289 · Cited by 669
Self-citationAntimicrobial resistance of Pseudomonas aeruginosa biofilms
Drenkard, E. (2003) · Microbes and Infection · doi:10.1016/j.micinf.2003.08.009 · Cited by 520
Production and Characterization of the Slime Polysaccharide of Pseudomonas aeruginosa
Evans, L. R., & Linker, A. (1973) · Journal of Bacteriology · doi:10.1128/jb.116.2.915-924.1973 · Cited by 428
Nivens, D. E., Ohman, D. E., Williams, J., & Franklin, M. J. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.3.1047-1057.2001 · Cited by 416
Pharmacokinetics and Bioavailability of Aerosolized Tobramycin in Cystic Fibrosis
Geller, D. E., Pitlick, W. H., Nardella, P. A., Tracewell, W. G., & Ramsey, B. W. (2002) · Chest · doi:10.1378/chest.122.1.219 · Cited by 300
Inhibition of tobramycin diffusion by binding to alginate
Nichols, W. W., Dorrington, S. M., Slack, M. P., & Walmsley, H. L. (1988) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.32.4.518 · Cited by 298
Govan, J. R. W., & Fyfe, J. A. M. (1978) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/4.3.233 · Cited by 228
Ohman, D. E., & Chakrabarty, A. M. (1981) · Infection and Immunity · doi:10.1128/iai.33.1.142-148.1981 · Cited by 213
Stapper, A. P., Narasimhan, G., Ohman, D. E., Barakat, J., Hentzer, M., Molin, S., Kharazmi, A., Høiby, N., & Mathee, K. (2004) · Journal of Medical Microbiology · doi:10.1099/jmm.0.45539-0 · Cited by 186
Hatch, R. A., & Schiller, N. L. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.4.974 · Cited by 177
Self-citationAaron, S. D., Ferris, W., Ramotar, K., Vandemheen, K. L., Chan, F., & Saginur, R. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.11.4172-4179.2002 · Cited by 148
Shawar, R. M., MacLeod, D. L., Garber, R. L., Burns, J. L., Stapp, J. R., Clausen, C. R., & Tanaka, S. K. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.12.2877 · Cited by 129
Bayer, A. S., Park, S., Ramos, M. C., Nast, C. C., Eftekhar, F., & Schiller, N. L. (1992) · Infection and Immunity · doi:10.1128/iai.60.10.3979-3985.1992 · Cited by 88
Self-citationCiofu, O., Fussing, V., Bagge, N., Koch, C., & Høiby, N. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/48.3.391 · Cited by 88
AlgX Is a Periplasmic Protein Required for Alginate Biosynthesis in Pseudomonas aeruginosa
Robles-Price, A. G., Wong, T. Y., Sletta, H., Valla, S., & Schiller, N. L. (2004) · Journal of Bacteriology · doi:10.1128/jb.186.21.7369-7377.2004 · Cited by 82
Self-citationDibdin, G. H., Assinder, S. J., Nichols, W. W., & Lambert, P. A. (1996) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/38.5.757 · Cited by 75
Ghani, M., & Soothill, J. S. (1997) · Canadian Journal of Microbiology · doi:10.1139/m97-144 · Cited by 62
Self-citationEftekhar, F., & Speert, D. P. (1988) · Infection and Immunity · doi:10.1128/iai.56.11.2788-2793.1988 · Cited by 48
Fowler, C. (1997) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/40.6.877 · Cited by 18
Andrés, M. T. A., Viejo‐Díaz, M., Pérez, F., & Fierro, J. F. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.4.1613-1616.2005 · Cited by 12
Cited by
Quorum sensing inhibitors: An overview
Kalia, V. C. (2013) · Biotechnology Advances · doi:10.1016/j.biotechadv.2012.10.004 · Cited by 971
Biofilm Dispersal: Mechanisms, Clinical Implications, and Potential Therapeutic Uses
Kaplan, J. B. (2010) · Journal of Dental Research · doi:10.1177/0022034509359403 · Cited by 949
“…promotes the detachment of cells from P. aeruginosa biofilms cultured on agar surfaces (Boyd and Chakrabarty, 1994), and exogenously added alginate lyase increases the effectiveness of some antibiotics against P. aeruginosa biofilms cultured in broth (Alkawash et al., 2006; Alipour et al., 2009).”
BackgroundBacterial Extracellular Polysaccharides in Biofilm Formation and Function
Limoli, D. H., Jones, C. J., & Wozniak, D. J. (2015) · Microbiology Spectrum · doi:10.1128/microbiolspec.mb-0011-2014 · Cited by 924
Role of polysaccharides in Pseudomonas aeruginosa biofilm development
Ryder, C., Byrd, M., & Wozniak, D. J. (2007) · Current Opinion in Microbiology · doi:10.1016/j.mib.2007.09.010 · Cited by 580
Rasamiravaka, T., Labtani, Q., Duez, P., & El Jaziri, M. (2015) · BioMed Research International · doi:10.1155/2015/759348 · Cited by 546
Metadata
- Authors
- ALKAWASH, M. A., SOOTHILL, J. S., & SCHILLER, N. L.
- Venue
- APMIS
- Publisher
- Wiley
- Published
- 2006-02
- Volume
- 114
- Issue
- 2
- Pages
- 131-138
- ISSN
- 0903-4641 (ISSN-L)
- 1600-0463
- OpenAlex
- W2006405242
- Cited by
- 276
- References
- 26
- FWCI
- 1.96
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.